How are you feeling today? Keep up to date on news and stories related to healthcare here!
Is it wiser to hold back the second doses everyone will need, or to give as many people as possible a shot now? There are concerns due to a supply constraint. Only Pfizer and Moderna vaccines are authorized, even though policymakers had
PRINCETON, N.J. — (BUSINESS WIRE) — $BMY #BMS—Bristol Myers Squibb (NYSE:BMY) today announced that the European Medicines Agency (EMA) validated its Marketing Authorization Application (MAA) for Opdivo (nivolumab) as an adjuvant treatment for esophageal or gastroesophageal junction (GEJ) cancer in adult patients
The virus has taken the life of a young American teacher who became famous for a 2018 video of her students. Meanwhile, confusion and shortages impede some U.S. vaccination campaigns. And, India has approved the Oxford-AstraZeneca vaccine and a local version.
Health workers participate in a COVID-19 vaccine delivery system trial in Hyderabad, India, Saturday, Jan. 2, 2021. India tested its COVID-19 vaccine delivery system with a nationwide trial on Saturday as it prepares to roll-out an inoculation program to stem the coronavirus
Other cases involving the highly contagious variant that was first identified in Britain have been found in Colorado, California, and now Florida. — NYT: Top Stories
PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #BMS—Bristol Myers Squibb (NYSE: BMY) today announced that the Biologics License Application (BLA) for lisocabtagene maraleucel (liso-cel) for the treatment of adults with relapsed or refractory (R/R) large B-cell lymphoma after at least two prior therapies remains under review
In the final weeks of 2020, the U.S. continues to set new records in cases and deaths. — NYT: Top Stories
This image provided by Lucy O’Donoghue shows a children playing by a lake. Although this year’s quarantine limited Lucy O’Donoghue’s opportunities for travel, she found ways to focus on her two sons by taking them for ‘micro-holidays’ at a beach near their
Marketing Authorization Application is supported by positive results from the pivotal Phase 3 True North study evaluating oral Zeposia (ozanimod) in adults with moderately to severely active ulcerative colitis If approved, Zeposia would be the first oral sphingosine-1-phosphate (S1P) receptor modulator for